ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Endocrinology, Diabetes Metabolism

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,186Medicare Part D Prescriptions Filled, Including Refills

Rank: 3 out of 99

$1.77M Total Retail Price of All Prescriptions

Rank: 4 out of 99

880 Patients Receiving at Least One Drug in Part D
63%Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

6% of this provider’s 880 patients filled at least one prescription for a schedule three drug, compared to an average of 2%.

Risky Drugs to Seniors

0% of this provider’s 9,508 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

38% of this provider’s prescriptions were for brand-name drugs, compared to an average of 46%.

Prescription Price

$116 was the average price of a prescription from this provider, compared to $120 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
LEVOTHYROXINE SODIUM 975 574 1 1
METFORMIN HCL ER 869 595 10 2 17
LANTUS 789 417 3 4
ATORVASTATIN CALCIUM 733 520 4 16
NOVOLOG 693 370 5 10
LISINOPRIL 597 349 6 11
INSULIN SYRINGE 545 290 7 6
GLIMEPIRIDE 536 358 8 7
FENOFIBRATE 475 289 9 32
CARVEDILOL 457 329 10 28
SIMVASTATIN 396 227 11 8
SYNTHROID 394 317 12 2
METFORMIN HCL 389 184 13 3
GABAPENTIN 294 164 14 22
NOVOLOG FLEXPEN 283 179 15 14
PEN NEEDLE 259 169 16 5
PRAVASTATIN SODIUM 258 162 17 18
HUMALOG 255 104 18 12
AMLODIPINE BESYLATE 250 170 19 13
HYDROCHLOROTHIAZIDE 241 172 20 23
LANTUS SOLOSTAR 231 134 21 9
LOVASTATIN 224 120 22 53
LISINOPRIL-HYDROCHLOROTHIAZIDE 181 137 23 38
ALENDRONATE SODIUM 181 148 23 35
CRESTOR 176 123 25 20
LOSARTAN POTASSIUM 155 145 26 21
JANUVIA 147 117 27 15
NOVOLOG MIX 70-30 FLEXPEN 138 95 28 31
HUMULIN N 133 68 29 42
NOVOLOG MIX 70-30 131 87 30 43
METHIMAZOLE 125 95 31 19
FUROSEMIDE 114 84 32 24
LIPITOR 104 46 33 66
ATENOLOL 100 65 34 40
TESTOSTERONE CYPIONATE 100 49 S3 34 84
HUMULIN R 96 52 36 49
GLIPIZIDE ER 94 74 37 36
HYDROCORTISONE 92 50 38 48
POTASSIUM CHLORIDE 91 83 39 52
LOSARTAN-HYDROCHLOROTHIAZIDE 85 44 40 46
FOSINOPRIL SODIUM 84 58 41 132
LEVOXYL 81 52 42 30
METOPROLOL TARTRATE 80 54 43 39
METOPROLOL SUCCINATE 75 51 44 37
ANDROGEL 72 37 S3 45 88
NOVOLIN N 72 57 45 61
ZETIA 65 28 47 47
DIOVAN 64 49 48 44
HUMALOG MIX 75-25 64 45 48 34
ACTOS 61 47 50 27
GEMFIBROZIL 61 39 50 67
DIOVAN HCT 60 27 52 76
GLIPIZIDE XL 58 58 53 56
BYETTA 56 47 54 50
NOVOLIN 70-30 53 47 55 29
KLOR-CON M20 51 25 56 78
AMITRIPTYLINE HCL 51 24 R 56 80
DESMOPRESSIN ACETATE 51 13 56 166
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.